Camlin Fine Sciences is currently trading at Rs. 114.70, up by 6.15 points or 5.67% from its previous closing of Rs. 108.55 on the BSE.
The scrip opened at Rs. 114.00 and has touched a high and low of Rs. 116.35 and Rs. 113.00 respectively. So far 96706 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 133.70 on 07-Dec-2020 and a 52 week low of Rs. 33.40 on 25-Mar-2020.
Last one week high and low of the scrip stood at Rs. 116.35 and Rs. 105.10 respectively. The current market cap of the company is Rs. 1452.69 crore.
The promoters holding in the company stood at 21.63%, while Institutions and Non-Institutions held 22.04% and 56.33% respectively.
Camlin Fine Sciences has received approval from board of directors for acquisition of 35% stake in its subsidiary namely, Dresen Quimica SAPI de CV (Dresen) from Controladora De Servicios Riso S.A.P.I. de C.V. (the joint venture partner) for an amount not exceeding $13 million, subject to regulatory approvals, if necessary and execution of definitive agreement by the Company with the joint venture partner.
Dresen is a joint venture between the Company and Controladora De Servicios Riso S.A.P.I. de C.V. in which the Company currently holds 65% stake. Post completion of the said acquisition, Dresen will become a wholly?owned subsidiary of the Company.
Camlin Fine Sciences is the world's second largest manufacturer and marketer of food grade antioxidants BHA (butylated hydroxyanisole) and TBHQ (Tertiary Butylhydroquinone).
Company Name | CMP |
---|---|
Tata Chemicals | 1069.40 |
SRF | 2165.85 |
Pidilite Inds. | 2958.60 |
Aarti Inds | 430.80 |
Atul | 7261.00 |
View more.. |